Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly syndrome characterized by a distinct facial phenotype, intellectual disability, epilepsy, Hirschsprung disease (HSCR) and variable congenital malformations.
Features include always present findings: Tooth malposition, Severe intellectual disability, Low hanging columella, and Delayed speech and language development; and common findings: Abnormal hippocampus morphology, Delayed eruption of teeth, Strabismus, and Short stature and others. 67 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 6 | Seizure, Aplasia/Hypoplasia of the cerebral white matter, Absent speech |
Eyes | 3 | Strabismus, Cataract, Ptosis |
Muscles | 3 | Low muscle tone (hypotonia), Generalized hypotonia, Generalized muscle hypertrophy |
Digestive system | 3 | Abdominal distention, Constipation, Vomiting |
Head and neck | 3 | Submucous cleft hard palate, Microcephaly, Cleft palate |
Heart and blood vessels | 3 | Ventricular septal defect, Abnormal heart morphology, Atrial septal defect |
Lungs and breathing | 2 | Pulmonary artery sling, Pulmonary artery stenosis |
Growth and development | 1 | Short stature |
Ears | 1 | Recurrent otitis media |
Kidneys and urinary system | 1 | Abnormality of the kidney |
Age of onset: infancy.
More than 340 individuals with classic Mowat-Wilson syndrome (MWS) have been reported in the medical literature . The male-to-female ratio is roughly equivalent (183:161), although earlier reports suggested a male predominance . Table 2. Classic Mowat-Wilson Syndrome: Frequency of Select Clinical Features
Clinical Feature | % of Persons w/Feature | Comment |
|---|---|---|
Epilepsy | 79% | May include electrical status epilepticus in sleep |
Microcephaly1 | 78% | — |
Hypospadias in males |
ZEB2 function has not been fully characterized.
Mowat-Wilson syndrome is caused by mutations in the ZEB2 gene on chromosome 2.
ZEB2 deletions and truncating pathogenic variants result in the typical facial features of classic MWS. Deletion sizes and breakpoints vary widely, with no obvious correlation between the phenotype and the size of the deletion, except for individuals with extremely large deletions (5 Mb) that include multiple adjacent genes. In general, those with a whole-gene deletion are more likely to have earlier onset of epilepsy and are at greater risk for epilepsy that is refractory to multiple medications compared to those in whom a defective protein is likely to be produced . Missense, splice site, or in-frame pathogenic variants in ZEB2 represent fewer than 5% of all reported cases and fewer than 2% of those with classic MWS (see also ).
Source: GeneReviews — "Classic Mowat-Wilson Syndrome"
Formal clinical diagnostic criteria for classic Mowat-Wilson syndrome (MWS) have not been published. However, the facial features are recognizable and, when accompanied by other features of the condition (e.g., Hirschsprung disease and/or chronic constipation, developmental delay/ intellectual disability), can establish a clinical diagnosis.
Classic MWS should be suspected in individuals with the following clinical and brain MRI findings and family history.
Clinical findings
Source: GeneReviews — "Classic Mowat-Wilson Syndrome"
Many of the congenital anomalies seen in classic Mowat-Wilson syndrome (MWS) can be seen as isolated anomalies in an otherwise normal individual. Genetic disorders with overlapping features are summarized in . Table 3. Genetic Disorders of Interest in the Differential Diagnosis of Classic Mowat-Wilson Syndrome
Gene(s) | Disorder | MOI | Clinical Features of Disorder |
|---|---|---|---|
CHD7 | CHARGE syndrome (See CHD7 Disorder.) | AD | Iris/retinal colobomas; Congenital heart defects; Cryptorchidism in males; ID |
EP300 |
Genetic testing for ZEB2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Mowat-Wilson syndrome has been reported in the published literature.
No approved treatments are currently available for Mowat-Wilson syndrome. The disease remains an area of unmet medical need.
Clinical management guidelines for Mowat-Wilson syndrome (MWS) have been published (full text).
To establish the extent of disease and needs of an individual diagnosed with classic MWS, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended.
Table 4.
Classic Mowat-Wilson Syndrome: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment
| Measurement of weight, length/height, head circumference | • To assess for growth restriction microcephaly
MWS-specific growth charts have been published.1
Eyes | Ophthalmologic eval | To assess for eye anomalies, strabismus, refractive error
Ears | Audiologic eval | To assess for hearing loss
| Dental eval | Early in childhood, typically starting at age ~3 yrs
| EKG echocardiogram, ideally w/cardiologist consultation | To assess for structural heart defects
| Assessment for signs symptoms of dysphagia | Consider VFSS for those w/suggestive features.
Assessment for history of chronic constipation | • Referral to GI specialist for eval of possible HSCR /or primary gut motility issues
Treatment of chronic constipation may improve rates of urinary incontinence.
| Abdominal ultrasound | To assess for structural renal anomalies presence of a spleen
Assessment for hypospadias /or cryptorchidism in males | Consider referral to urologist.
Source: GeneReviews — "Classic Mowat-Wilson Syndrome"
At least one individual with tantrums and difficulties focusing had worsening aggression after a trial of stimulant medication . Stimulant medication should be used with caution in individuals with classic MWS.
Source: GeneReviews — "Classic Mowat-Wilson Syndrome"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Classic Mowat-Wilson Syndrome"
1 trial found
The specific features present in any given individual typically guide surveillance. Follow up with a cardiologist, gastroenterologist, neurologist, urologist, and developmental pediatrician as clinically indicated is recommended. In addition, the evaluations summarized in should be considered. Table 6. Classic Mowat-Wilson Syndrome: Recommended Surveillance
System/Concern | Evaluation | Frequency |
|---|---|---|
Constitutional | Assessment of growth parameters | Every 6 mos for 1st 3 yrs of life, then annually; MWS-specific growth charts have been published.1 |
Eyes | Ophthalmologic eval | Annually until age 6 yrs or based on clinical concerns |
Ears | Audiologic eval | Annually until age 3 yrs, then based on clinical concerns |
Mouth | Dental eval | At least annually |
Gastrointestinal | Assessment for chronic constipation | At each visit Neurologic |
Development | Monitor developmental progress educational needs. | At each visit during childhood adolescence |
Family/Community | Assess family need for social work support (e.g., respite care, home nursing; other local resources) care coordination. | At each visit 1. (full text) |
Source: GeneReviews — "Classic Mowat-Wilson Syndrome"
Phenotype severity distribution: 4 always present features, 17 common features.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
30 publications have been identified in PubMed for Mowat-Wilson syndrome. Research spans Case Report / Case Series (43%), Basic Science / Preclinical (33%), and Review / Meta-Analysis (7%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 13 | 43% |
Laboratory research | 10 | 33% |
Research summaries | 2 | 7% |
Clinical study results | 2 | 7% |
Disease patterns and progression | 2 | 7% |
Testing and diagnosis research | 1 | 3% |
Martain-Pérez I (2026). [PMID: 42184404](https://pubmed.ncbi.nlm.nih.gov/42184404/). *Bol Med Hosp Infant Mex*. [Case Report / Case Series]
Huang X (2026). [PMID: 41896167](https://pubmed.ncbi.nlm.nih.gov/41896167/). *J Paediatr Child Health*. [Case Report / Case Series]
Chen J (2026). [PMID: 41788411](https://pubmed.ncbi.nlm.nih.gov/41788411/). *Frontiers in genetics*. [Case Report / Case Series]
Musante I (2026). [PMID: 41325909](https://pubmed.ncbi.nlm.nih.gov/41325909/). *Neurobiology of disease*. [Basic Science / Preclinical]
Kumar S (2026). [PMID: 41576029](https://pubmed.ncbi.nlm.nih.gov/41576029/). *PLoS genetics*. [Basic Science / Preclinical]
Collins S (2026). [PMID: 41929340](https://pubmed.ncbi.nlm.nih.gov/41929340/). *medRxiv*. [Basic Science / Preclinical]
Peng N (2026). [PMID: 41975932](https://pubmed.ncbi.nlm.nih.gov/41975932/). *Healthcare (Basel)*. [Epidemiology / Natural History]
Liu L (2026). [PMID: 42038223](https://pubmed.ncbi.nlm.nih.gov/42038223/). *Front Pediatr*. [Clinical Trial Publication]
Nie S (2025). [PMID: 40714467](https://pubmed.ncbi.nlm.nih.gov/40714467/). *International immunopharmacology*. [Basic Science / Preclinical]
Haviland I (2025). [PMID: 39205479](https://pubmed.ncbi.nlm.nih.gov/39205479/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Data assembled from 9 of 12 sources · Last updated Oct 3, 2026, 10:45 AM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
60%
— |
Congenital heart defects | 58% | Particularly anomalies of pulmonary arteries /or valves |
Short stature2 | 46% | — |
Hirschsprung disease | 44% | — |
Cryptorchidism in males | 41% | — |
Constipation (w/o known Hirschsprung disease) | 29% | — |
Renal anomalies | 25% | — |
Structural eye anomalies | 10% | — |
Pyloric stenosis | 7% | — |
Pulmonary artery sling | 3% | — |
Cleft palate | 2% | Adapted from 1. Head circumference ≥2 standard deviations below the mean for age and sex 2. Length or height ≥2 standard deviations below the mean for age and sex Distinctive craniofacial features are a hallmark of classic MWS and, therefore, are one of the most specific findings (see and ). |
Source: GeneReviews — "Classic Mowat-Wilson Syndrome"
AD |
Nasal configuration Note: Several persons w/classic MWS have had broad thumbs great toes; at least 1 had radial deviation of thumbs great toes similar to hand foot findings in RSTS.1 |
DHCR7 | Smith-Lemli-Opitz syndrome2 | AR | Hypospadias in males; Microcephaly; ID |
KIF1BP | Goldberg-Shprintzen syndrome (OMIM 609460) | AR | HSCR; Microcephaly; ID |
Higher frequency of cleft palate, ptosis, ocular coloboma than in classic MWS TCF4 pathogenic variant or 18q21.2 deletion involving TCF4 | Pitt-Hopkins syndrome (PTHS) | AD | Significant ID; Mean age of walking: 4-6 yrs; Absent or severely impaired verbal language; Behavioral issues; Stereotypic hand movements; Seizures; Microcephaly; Constipation |
Angelman syndrome | See footnote 3. | Absent speech; Hypopigmentation; Seizures; Microcephaly; Ataxic-like gait Note: In infancy, only hypotonia may be evident. | Absence of multitude of congenital anomalies characteristic facial features of MWS AD = autosomal dominant; AR = autosomal recessive; HSCR = Hirschsprung disease; ID = intellectual disability; MOI = mode of inheritance; MWS = Mowat-Wilson syndrome 1. |
Source: GeneReviews — "Classic Mowat-Wilson Syndrome"